Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Exosome Diagnostics, Inc.
Exosome Diagnostics Announces Additions to Management Team
September 16th, 2008
Exosome Diagnostics, Inc. announced additions to its management team as the company moves forward with development of its blood-based diagnostics that can identify cancer-specific genetic mutations. Wayne D. Comper, Ph.D., D.Sc., has joined Exosome Diagnostics as the chief scientific officer. Dr. Comper has extensive experience both as a biotechnology executive and as a biomedical research scientist. Prior to joining Exosome, he was chief science officer of AusAm Biotechnologies, Inc., a company developing diagnostics and therapeutics to identify and treat kidney, cardiovascular and infectious diseases. Dr. Comper has also published over 160 articles in peer-reviewed...
Source: Cancer Weekly (2008-09-16)
|
